Marc Pascal

Identification and Biological Activity of the Active Metabolite of Clopidogrel

Pierre Savi, Jean‐Marie Pereillo, Marie-Françoise Uzabiaga et al. · Thrombosis and Haemostasis · 2000 · 748 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V _1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Guy Griebel, Jacques Simiand, Claudine Serradeil‐Le Gal et al. · Proceedings of the National Academy of Sciences · 2002 · 462 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Structure and Stereochemistry of the Active Metabolite of Clopidogrel

Jean‐Marie Pereillo, Mohamed Maftouh, Alain Andrieu et al. · Drug Metabolism and Disposition · 2002 · 458 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist

Claudine Serradeil‐Le Gal, Jean Wagnon, Jacques Simiand et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 210 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes

Claudine Serradeil-Le Gal, Max Lafontan, Danielle Raufaste et al. · FEBS Letters · 2000 · 75 citations

Medicine, Endocrinology, Pharmacology +17